chr11-71582792-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005405.3(KRTAP5-11):c.46G>A(p.Gly16Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,610,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005405.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP5-11 | NM_001005405.3 | c.46G>A | p.Gly16Ser | missense_variant | 1/1 | ENST00000398530.1 | NP_001005405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP5-11 | ENST00000398530.1 | c.46G>A | p.Gly16Ser | missense_variant | 1/1 | 6 | NM_001005405.3 | ENSP00000381541.1 | ||
KRTAP5-11 | ENST00000526239.1 | n.381-635G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 151986Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000252 AC: 63AN: 250182Hom.: 0 AF XY: 0.000266 AC XY: 36AN XY: 135538
GnomAD4 exome AF: 0.000362 AC: 528AN: 1458794Hom.: 0 Cov.: 31 AF XY: 0.000368 AC XY: 267AN XY: 725686
GnomAD4 genome AF: 0.000191 AC: 29AN: 151986Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74244
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.46G>A (p.G16S) alteration is located in exon 1 (coding exon 1) of the KRTAP5-11 gene. This alteration results from a G to A substitution at nucleotide position 46, causing the glycine (G) at amino acid position 16 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at